Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$80.53

-0.91 (-1.12%)

16:03
08/09/17
08/09
16:03
08/09/17
16:03

Alnylam reports cash, equivalents and fixed income securities $1.25B at June 30

At June 30 Alnylam had cash, cash equivalents and fixed income marketable securities, and restricted investments of $1.25B, as compared to $1.09B at December 31, 2016.

  • 09

    Aug

  • 09

    Aug

  • 23

    Aug

  • 07

    Sep

  • 12

    Sep

ALNY Alnylam
$80.53

-0.91 (-1.12%)

07/11/17
BMOC
07/11/17
NO CHANGE
BMOC
Alnylam weakness creates buying opportunity, says BMO Capital
BMO Capital analyst Do Kim says that the weakness of Alnylam's stock was caused by increases in ALT associated with the company's fitusiran drug. But the analyst says that such increases are "transient and asymptomatic," and Kim believes that the drug is superior to competing products. Kim recommends buying the stock on weakness.
07/11/17
COWN
07/11/17
NO CHANGE
Target $325
COWN
Outperform
Shire hemophilia franchise being valued near zero, says Cowen
Cowen analyst Ken Cacciatore believes Shire's (SHPG) current valuation reflects essentially no value for the company's hemophilia franchise. Investors are treating Shire/Baxalta's hemophilia franchise as if it should equate to essentially zero, into perpetuity, beginning in 2020, Cacciatore tells investors in a research note, citing his analysis. He believes this sentiment, based on competitive concerns from Roche (RHHBY) and Alnylam (ALNY), is a "gross overreaction." The analyst has an Outperform rating on Shire with a $325 price target.
07/17/17
LTCO
07/17/17
NO CHANGE
Target $90
LTCO
Buy
Alnylam price target raised to $90 from $80 at Ladenburg
Ladenburg Thalmann analyst Christopher James raised his price target for Alnylam Pharmaceuticals to $90 ahead of the upcoming Phase 3 APOLLO readout with patisiran. The analyst says his new target reflects increased confidence in a positive readout. He upped his probability of success for patisiran to 80% from 70% and keeps a Buy rating on Alnylam.
07/27/17
BERN
07/27/17
INITIATION
BERN
Outperform
Alnylam initiated with an Outperform at Bernstein
Bernstein analyst Vincent Chen started coverage of Alnylam with a $99 price target and an Outperform rating. He says that Alnylam " combines high-value late-stage assets with visible catalysts, and an increasingly de-risked RNA platform." The analyst adds that the company's assets are "high value and exciting," The analyst is upbeat on several of the company's late-stage therapies, including patisiran. He expects the latter therapy to obtain the "lion's share" of the TTR market.

TODAY'S FREE FLY STORIES

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.47

-0.06 (-0.07%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$120.46

0.15 (0.12%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$126.39

0.93 (0.74%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$24.99

-0.16 (-0.64%)

, BA

Boeing

$262.26

-1.44 (-0.55%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Periodicals
Airbus faces challenges over stalled A380 Emirates deal, Reuters reports »

Airbus (EADSY) is facing…

EADSY

Airbus

$24.99

-0.16 (-0.64%)

BA

Boeing

$262.26

-1.44 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Hot Stocks
Altice: Majority investor Next does not hold any margin loan exposure to Altice »

Information service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$16.31

0.19 (1.18%)

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USLV

VelocityShares 3x Long Silver ETN

$12.56

0.45 (3.72%)

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Hot Stocks
Breaking Hot Stocks news story on Altice »

Altice says will not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$82.14

-0.38 (-0.46%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

, ATUS

Altice USA

$19.86

-0.38 (-1.88%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Periodicals
Altice says not in preparation of cash raising by means of equity issuance »

Altice N.V. (ATCEY)…

ATCEY

Altice

ATUS

Altice USA

$19.86

-0.38 (-1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Hot Stocks
Breaking Hot Stocks news story on Altice »

Altice: Management has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBB

iShares Nasdaq Biotechnology Index

$311.21

0.4 (0.13%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYAAY

Ryanair

$118.88

1.45 (1.23%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Initiation
Ryanair initiated  »

Ryanair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$5.40

0.01 (0.19%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$25.43

-0.17 (-0.66%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$1.94

0.04 (2.11%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Recommendations
Avon Products analyst commentary  »

Coty may consider…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$32.71

-0.16 (-0.49%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IJR

iShares Core S&P Small Cap ETF

$74.63

0.32 (0.43%)

06:31
11/20/17
11/20
06:31
11/20/17
06:31
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$46.82

0.23 (0.49%)

06:31
11/20/17
11/20
06:31
11/20/17
06:31
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$50.26

0.48 (0.96%)

06:30
11/20/17
11/20
06:30
11/20/17
06:30
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$24.34

-0.07 (-0.29%)

06:30
11/20/17
11/20
06:30
11/20/17
06:30
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$22.13

0.07 (0.32%)

06:29
11/20/17
11/20
06:29
11/20/17
06:29
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$97.47

-2.15 (-2.16%)

06:28
11/20/17
11/20
06:28
11/20/17
06:28
Downgrade
Wal-Mart rating change  »

Wal-Mart downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 20

    Feb

VZ

Verizon

$45.42

0.65 (1.45%)

06:27
11/20/17
11/20
06:27
11/20/17
06:27
Upgrade
Verizon rating change  »

Verizon upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

$272.20

1.55 (0.57%)

06:24
11/20/17
11/20
06:24
11/20/17
06:24
Conference/Events
Mohawk management to meet with Evercore ISI »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.